MDxHealth is trading at $0.56, up +7.63%, with no clear company-specific catalyst identified for the September 30 move.
- The company’s 2026 press-release archive lists August 13 as its latest release.
- Broader markets are higher, with the Nasdaq up 0.90% and the S&P 500 up 0.59%, offering a possible risk-on backdrop.
- Healthcare is down 1.33%, so sector performance does not explain the rise; no direct cause is confirmed.